>
pdufa.bio

Briquilimab

Updated ยทnext FDA decision on the calendar

Briquilimab is a Jasper Therapeutics, Inc. program. Every date links its source.

JSPR catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Jasper Therapeutics, Inc. (JSPR). We track 2 catalyst events for this program: 0 upcoming and 2 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jul 2026JSPRReadout · Jul 2026JSPR

Questions

When is Briquilimab's next FDA decision or readout?

No upcoming catalyst is on our calendar for Briquilimab; no FDA decisions are on record below.

What happened at Briquilimab's most recent FDA decision?

No FDA decision for Briquilimab is in our archive yet.

Who makes Briquilimab?

Jasper Therapeutics, Inc. (JSPR).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.